-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medical Network News, August 13, 2021.
In July 2021, the total number of newly launched clinical trials led by corporate capital in the world was 764, which was 11.
68% lower than the number in June and accounted for 16.
61% of the total in the first half of 2021.
Average level from January to July
.
In July 2021, the total number of newly launched clinical trials led by corporate capital in the world was 764, which was 11.
68% lower than the number in June and accounted for 16.
61% of the total in the first half of 2021.
Average level from January to July
.
July, reporting the largest number of clinical trials company Novartis, to declare the number is 19; followed by Bristol-Myers Squibb and Pfizer, respectively, 18 and 16
.
The company with the largest increase in the number of clinical trials in July was Johnson & Johnson, with a monthly increase of 180%; followed by Bristol-Myers Squibb, with an increase of 80%
.
.
The company with the largest increase in the number of clinical trials in July was Johnson & Johnson, with a monthly increase of 180%; followed by Bristol-Myers Squibb, with an increase of 80%
.
From the ranking data, the biggest change is Roche
.
As of July, Roche ranked 6th in 2021, up 4 places compared to 2020
.
In addition, the current rankings of Novartis, Johnson & Johnson and Takeda Pharmaceutical have also risen by 3 places compared to 2020
.
.
As of July, Roche ranked 6th in 2021, up 4 places compared to 2020
.
In addition, the current rankings of Novartis, Johnson & Johnson and Takeda Pharmaceutical have also risen by 3 places compared to 2020
.
Judging from the hot indication areas of clinical trials in July, this month’s tissue classification tumor is still the most popular R&D area, with 93 clinical trials; followed by infectious diseases and immune system diseases , with 82 and 82 items respectively.
73 items
.
Judging from the increase in data, the most significant increase in indications for new clinical trials in July was infectious diseases and viral diseases, and the decline in immune system diseases was more obvious (see table)
.
73 items
.
Judging from the increase in data, the most significant increase in indications for new clinical trials in July was infectious diseases and viral diseases, and the decline in immune system diseases was more obvious (see table)
.
From the perspective of drug types, statistics on the number of newly launched clinical trials found that among the top 10 popular drug types, the most significant drug types are vaccines and antimetabolites
.
.
After statistics on the origin of clinical trial applications, it is found that the United States is still the most important country for clinical trials; followed by China and Germany
.
The most significant increases were Poland and Italy, with monthly increases of 28.
57% and 24.
14% respectively
.
The largest decline was in the United States, at -20.
00%
.
(Data source for this article: US Clinical Trial Database)
.
The most significant increases were Poland and Italy, with monthly increases of 28.
57% and 24.
14% respectively
.
The largest decline was in the United States, at -20.
00%
.
(Data source for this article: US Clinical Trial Database)
Medical Network News, August 13, 2021.
In July 2021, the total number of newly launched clinical trials led by corporate capital in the world was 764, which was 11.
68% lower than the number in June and accounted for 16.
61% of the total in the first half of 2021.
Average level from January to July
.
In July 2021, the total number of newly launched clinical trials led by corporate capital in the world was 764, which was 11.
68% lower than the number in June and accounted for 16.
61% of the total in the first half of 2021.
Average level from January to July
.
July, reporting the largest number of clinical trials company Novartis, to declare the number is 19; followed by Bristol-Myers Squibb and Pfizer, respectively, 18 and 16
.
The company with the largest increase in the number of clinical trials in July was Johnson & Johnson, with a monthly increase of 180%; followed by Bristol-Myers Squibb, with an increase of 80%
.
.
The company with the largest increase in the number of clinical trials in July was Johnson & Johnson, with a monthly increase of 180%; followed by Bristol-Myers Squibb, with an increase of 80%
.
From the ranking data, the biggest change is Roche
.
As of July, Roche ranked 6th in 2021, up 4 places compared to 2020
.
In addition, the current rankings of Novartis, Johnson & Johnson and Takeda Pharmaceutical have also risen by 3 places compared to 2020
.
.
As of July, Roche ranked 6th in 2021, up 4 places compared to 2020
.
In addition, the current rankings of Novartis, Johnson & Johnson and Takeda Pharmaceutical have also risen by 3 places compared to 2020
.
Judging from the hot indication areas of clinical trials in July, this month’s tissue classification tumor is still the most popular R&D area, with 93 clinical trials; followed by infectious diseases and immune system diseases , with 82 and 82 items respectively.
73 items
.
Judging from the increase in data, the most significant increase in indications for new clinical trials in July was infectious diseases and viral diseases, and the decline in immune system diseases was more obvious (see table)
.
73 items
.
Judging from the increase in data, the most significant increase in indications for new clinical trials in July was infectious diseases and viral diseases, and the decline in immune system diseases was more obvious (see table)
.
From the perspective of drug types, statistics on the number of newly launched clinical trials found that among the top 10 popular drug types, the most significant drug types are vaccines and antimetabolites
.
.
After statistics on the origin of clinical trial applications, it is found that the United States is still the most important country for clinical trials; followed by China and Germany
.
The most significant increases were Poland and Italy, with monthly increases of 28.
57% and 24.
14% respectively
.
The largest decline was in the United States, at -20.
00%
.
(Data source for this article: US Clinical Trial Database)
.
The most significant increases were Poland and Italy, with monthly increases of 28.
57% and 24.
14% respectively
.
The largest decline was in the United States, at -20.
00%
.
(Data source for this article: US Clinical Trial Database)
Medical Network News, August 13, 2021.
In July 2021, the total number of newly launched clinical trials led by corporate capital in the world was 764, which was 11.
68% lower than the number in June and accounted for 16.
61% of the total in the first half of 2021.
Average level from January to July
.
In July 2021, the total number of newly launched clinical trials led by corporate capital in the world was 764, which was 11.
68% lower than the number in June and accounted for 16.
61% of the total in the first half of 2021.
Average level from January to July
.
July, reporting the largest number of clinical trials company Novartis, to declare the number is 19; followed by Bristol-Myers Squibb and Pfizer, respectively, 18 and 16
.
The company with the largest increase in the number of clinical trials in July was Johnson & Johnson, with a monthly increase of 180%; followed by Bristol-Myers Squibb, with an increase of 80%
.
Enterprise business enterprise.
The company with the largest increase in the number of clinical trials in July was Johnson & Johnson, with a monthly increase of 180%; followed by Bristol-Myers Squibb, with an increase of 80%
.
From the ranking data, the biggest change is Roche
.
As of July, Roche ranked 6th in 2021, up 4 places compared to 2020
.
In addition, the current rankings of Novartis, Johnson & Johnson and Takeda Pharmaceutical have also risen by 3 places compared to 2020
.
.
As of July, Roche ranked 6th in 2021, up 4 places compared to 2020
.
In addition, the current rankings of Novartis, Johnson & Johnson and Takeda Pharmaceutical have also risen by 3 places compared to 2020
.
Judging from the hot indication areas of clinical trials in July, this month’s tissue classification tumor is still the most popular R&D area, with 93 clinical trials; followed by infectious diseases and immune system diseases , with 82 and 82 items respectively.
73 items
.
Judging from the increase in data, the most significant increase in indications for new clinical trials in July was infectious diseases and viral diseases, and the decline in immune system diseases was more obvious (see table)
.
Tumor tumor tumor disease disease disease73 items
.
Judging from the increase in data, the most significant increase in indications for new clinical trials in July was infectious diseases and viral diseases, and the decline in immune system diseases was more obvious (see table)
.
From the perspective of drug types, statistics on the number of newly launched clinical trials found that among the top 10 popular drug types, the most significant drug types are vaccines and antimetabolites
.
.
After statistics on the origin of clinical trial applications, it is found that the United States is still the most important country for clinical trials; followed by China and Germany
.
The most significant increases were Poland and Italy, with monthly increases of 28.
57% and 24.
14% respectively
.
The largest decline was in the United States, at -20.
00%
.
(Data source for this article: US Clinical Trial Database)
.
The most significant increases were Poland and Italy, with monthly increases of 28.
57% and 24.
14% respectively
.
The largest decline was in the United States, at -20.
00%
.
(Data source for this article: US Clinical Trial Database)
